Mairs & Power Inc Eli Lilly & CO Transaction History

Mairs & Power Inc

$10.2 Billion
Q1 2024

A detailed history of Mairs & Power Inc transactions in Eli Lilly & CO stock. As of the latest transaction made, Mairs & Power Inc holds 364,467 shares of LLY stock, worth $330 Million. This represents 2.77% of its overall portfolio holdings.

Number of Shares

364,467

Previous 392,689 7.19%

Holding current value

$330 Million

Previous $229 Million 23.87%

% of portfolio

2.77%

Previous 2.42%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$592.2 - $792.28 $16.7 Million - $22.4 Million	-28,222 Reduced 7.19%	364,467 $284 Million
Q4 2023 Feb 14, 2024	SELL	$525.19 - $619.13 $17.7 Million - $20.8 Million	-33,619 Reduced 7.89%	392,689 $229 Million
Q3 2023 Nov 14, 2023	SELL	$434.7 - $599.3 $21.1 Million - $29.1 Million	-48,513 Reduced 10.22%	426,308 $229 Million
Q2 2023 Aug 14, 2023	SELL	$350.74 - $468.98 $25.8 Million - $34.5 Million	-73,617 Reduced 13.42%	474,821 $223 Million
Q1 2023 May 15, 2023	BUY	$310.63 - $364.82 $20.4 Million - $23.9 Million	65,590 Added 13.58%	548,438 $188 Million

Q4 2022 Feb 14, 2023	SELL	$321.55 - $374.67 $4.89 Million - $5.7 Million	-15,205 Reduced 3.05%	482,848 $177 Million
Q3 2022 Nov 14, 2022	SELL	$296.48 - $337.87 $7.77 Million - $8.85 Million	-26,191 Reduced 5.0%	498,053 $161 Million
Q2 2022 Aug 15, 2022	SELL	$278.73 - $327.27 $35.5 Million - $41.7 Million	-127,268 Reduced 19.53%	524,244 $170 Million
Q1 2022 May 16, 2022	SELL	$234.69 - $291.66 $2.7 Million - $3.35 Million	-11,502 Reduced 1.73%	651,512 $187 Million
Q4 2021 Feb 14, 2022	SELL	$224.85 - $279.04 $42,946 - $53,296	-191 Reduced 0.03%	663,014 $183 Million
Q3 2021 Nov 15, 2021	SELL	$221.6 - $272.71 $2.98 Million - $3.67 Million	-13,461 Reduced 1.99%	663,205 $153 Million
Q2 2021 Aug 16, 2021	SELL	$180.55 - $233.54 $1.46 Million - $1.88 Million	-8,068 Reduced 1.18%	676,666 $155 Million
Q1 2021 May 14, 2021	SELL	$164.32 - $212.72 $4.66 Million - $6.03 Million	-28,342 Reduced 3.97%	684,734 $128 Million
Q4 2020 Feb 16, 2021	BUY	$130.46 - $172.63 $3.38 Million - $4.47 Million	25,912 Added 3.77%	713,076 $120 Million
Q3 2020 Nov 16, 2020	SELL	$146.22 - $169.13 $2.1 Million - $2.43 Million	-14,368 Reduced 2.05%	687,164 $102 Million
Q2 2020 Aug 14, 2020	SELL	$136.42 - $164.18 $14.3 Million - $17.2 Million	-104,547 Reduced 12.97%	701,532 $115 Million
Q1 2020 May 15, 2020	SELL	$119.05 - $147.35 $5.75 Million - $7.12 Million	-48,325 Reduced 5.66%	806,079 $112 Million
Q4 2019 Feb 14, 2020	BUY	$106.92 - $132.43 $14.1 Million - $17.5 Million	131,851 Added 18.25%	854,404 $112 Million
Q3 2019 Nov 14, 2019	BUY	$106.79 - $116.16 $4.87 Million - $5.3 Million	45,647 Added 6.74%	722,553 $80.8 Million
Q2 2019 Aug 14, 2019	SELL	$110.79 - $129.32 $1.27 Million - $1.48 Million	-11,432 Reduced 1.66%	676,906 $75 Million
Q1 2019 May 15, 2019	SELL	$111.31 - $131.02 $17.4 Million - $20.5 Million	-156,371 Reduced 18.51%	688,338 $89.3 Million
Q4 2018 Feb 14, 2019	SELL	$105.9 - $118.64 $9.9 Million - $11.1 Million	-93,469 Reduced 9.96%	844,709 $97.8 Million
Q3 2018 Nov 14, 2018	SELL	$85.86 - $107.31 $8.44 Million - $10.5 Million	-98,300 Reduced 9.48%	938,178 $101 Million
Q2 2018 Aug 14, 2018	SELL	$75.7 - $86.88 $213,095 - $244,567	-2,815 Reduced 0.27%	1,036,478 $88.4 Million
Q1 2018 May 15, 2018	BUY	$74.21 - $87.6 $1.84 Million - $2.17 Million	24,812 Added 2.45%	1,039,293 $80.4 Million
Q4 2017 Feb 14, 2018	BUY	$81.94 - $87.89 $3.08 Million - $3.3 Million	37,532 Added 3.84%	1,014,481 $85.7 Million
Q3 2017 Nov 14, 2017	BUY	$77.07 - $85.54 $75.3 Million - $83.6 Million	976,949	976,949 $83.6 Million

Others Institutions Holding LLY

# of Institutions

3,719

Shares Held

738M

Call Options Held

7.09M

Put Options Held

7.24M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $860B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mairs & Power Inc, based on Form 13F filings with the SEC.

News

Stay updated on Mairs & Power Inc with notifications on news.

Account